We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Approves AstraZeneca’s Duaklir Genuair for COPD
EMA Approves AstraZeneca’s Duaklir Genuair for COPD
The European Medicines Agency has approved AstraZeneca’s Duaklir Genuair as a maintenance treatment for patients with chronic obstructive pulmonary disease.